← FDA Drug Approvals (Drugs@FDA)

ESCITALOPRAM OXALATE

ANDA · Abbreviated New Drug Application (Generic) · Sponsor: HETERO LABS LTD III · Approved 2012-06-12

Drug application

FDA Application #

ANDA202221

Application type

Abbreviated New Drug Application (Generic)

Brand name

ESCITALOPRAM OXALATE

Generic name

ESCITALOPRAM OXALATE

Active ingredients

ESCITALOPRAM OXALATE

Dosage form

SOLUTION

Route

ORAL

Marketing status

Prescription

Sponsor

HETERO LABS LTD III

Manufacturer

Camber Pharmaceuticals, Inc.

First approval

2012-06-12

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown